CTO: Length’s Impact on Success

The rise of chronic total occlusions (CTO) percutaneous coronary interventions (PCI) goes hand in hand with technological development, through still posing a great challenge, one not exactly exempt from complications. 

CTO: la longitud impacta en el éxito

An important criterion to successful CTO PCI is length: ≥20 mm lesions lower the odds, according to J-CTO Score. However, increasing operator experience and the development of new guidewires and micro-catheters is gradually changing the situation.

The study looked at 10335 CTO PCI performed between 2012 and 2022. 7208 of these interventions were ≥20 mm long (69.7%) and 3127 <20 mm long (30.3%).

Mean age was similar in both groups, but those with ≥20 mm occlusions were more often men, smokers, presenting hypertension, dyslipidemia, diabetes, peripheral vascular disease, cardiac failure, lower ejection fraction, MI, and CABG. 

The artery that more frequently presented CTO was the right coronary (57.3%), followed by the anterior descending (23.4%) and the circumflex.

Read also: ISAR Score: Can We Predict the Need for Repeat PCI in DES Restenosis?

≥20 mm occlusions presented more unfavorable angiographic characteristics, more tortuosity, and severe calcification. Also, the dissection and reentry technique was more often used in the group, as well as the retrograde strategy.

Crossing success rate was lower in patients presenting longer lesions, who also needed more stents, longer fluoroscopy time and longer procedures. 

≥20 mm lesions were associated to lower technical and procedural success (84.4% vs. 91.8%; p < 0.001 and 81.9% vs. 90.3%; p < 0.001 respectively). In hospital MACE was higher in this group (3.4% vs. 1.9%; p < 0.001), as was AMI (0.7% vs. 0.26%; p = 0.009), perforations (5.15% vs. 3.87%; p = 0.007) and the presence of thrombi and dissection (0.84% vs. 0.35%; p = 0.008).

Read also: Percutaneous Access Closure in TAVR: Are Devices Similar?

A 10 mm increase in occlusion length was associated to lower technical success rate. 

After multivariable analysis, (shorter) lesion length was associated to reduced MACE and technical success. 

Conclusion

CTO PCI of long occlusions is independently associated with lower rates of technical success and higher rates of in-hospital MACE. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS‐CTO registry.

Reference: Athanasios Rempakos, et al. Catheter Cardiovasc Interv. 2023;101:747–755.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...